Comparison of Cervical Pap Smears with Positive High-risk Human Papillomavirus (hrHPV) Tests with Non-HPV 16/18/45 HPV Subtypes and HPV 16/18/45 Subtypes Including Cytohistologic Correlation

被引：0
|
作者：
Addo, Jennifer [1 ]
Brown, Cameron [1 ]
Xu, Ya [1 ]
机构：
[1] Baylor Coll Med, Houston, TX USA
来源：
LABORATORY INVESTIGATION | 2024年 / 104卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1595
引用
收藏
页码：S1977 / S1977
页数：1
相关论文
共 50 条
  • [1] Comparing Outcomes of hrHPV Positive Pap Tests: HPV 16/18 Genotypes Versus Non-16/18 Genotypes
    Alsaati, Gazal
    Laureano, Julio
    Sidawy, Mary K.
    Zeck, Jay
    LABORATORY INVESTIGATION, 2016, 96 : 88A - 88A
  • [2] Comparing Outcomes of hrHPV Positive Pap Tests: HPV 16/18 Genotypes Versus Non-16/18 Genotypes
    Alsaati, Gazal
    Laureano, Julio
    Sidawy, Mary K.
    Zeck, Jay
    MODERN PATHOLOGY, 2016, 29 : 88A - 88A
  • [3] Detection of high-risk human papillomavirus RNA in urine for cervical cancer screening with HPV 16 & 18/45 genotyping
    Padhy, Radha Rani
    Davidov, Adi
    Madrigal, Louise
    Alcide, Gina
    Spahiu, Almir
    HELIYON, 2020, 6 (04)
  • [4] Primary Screening for Cervical Cancer Based on High-Risk Human Papillomavirus (HPV) Detection and HPV 16 and HPV 18 Genotyping, in Comparison to Cytology
    Agorastos, Theodoros
    Chatzistamatiou, Kimon
    Katsamagkas, Taxiarchis
    Koliopoulos, George
    Daponte, Alexandros
    Constantinidis, Theocharis
    Constantinidis, Theodoros C.
    PLOS ONE, 2015, 10 (03):
  • [5] Comparison of the immunogenicity of the human papillomavirus (HPV)-16/18 vaccine and the HPV-6/11/16/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18-45 years
    Einstein, Mark H.
    Baron, Mira
    Levin, Myron J.
    Chatterjee, Archana
    Fox, Bradley
    Scholar, Sofia
    Rosen, Jeffrey
    Chakhtoura, Nahida
    Lebacq, Marie
    van der Most, Robbert
    Moris, Philippe
    Giannini, Sandra L.
    Schuind, Anne
    Datta, Sanjoy K.
    Descamps, Dominique
    HUMAN VACCINES, 2011, 7 (12): : 1359 - 1373
  • [6] Role of Non-HPV 16 and 18 Types in Cervical High Grade Neoplasia
    Pillappa, Raghavendra
    Neil, Brock
    Bugg, Michael
    LABORATORY INVESTIGATION, 2015, 95 : 102A - 103A
  • [7] Role of Non-HPV 16 and 18 Types in Cervical High Grade Neoplasia
    Pillappa, Raghavendra
    Neil, Brock
    Bugg, Michael
    MODERN PATHOLOGY, 2015, 28 : 102A - 103A
  • [8] Can human papillomavirus (HPV) genotyping classify non-16/18 high-risk HPV infection by risk stratification?
    Sung, Yeoun Eun
    Ki, Eun Young
    Lee, Youn Soo
    Hur, Soo Young
    Lee, Ahwon
    Park, Jong Sup
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2016, 27 (06)
  • [9] Comparison of the Cobas 4800 HPV and HPV 9G DNA Chip Tests for Detection of High-Risk Human Papillomavirus in Cervical Specimens of Women with Consecutive Positive HPV Tests But Negative Pap Smears
    Jun, Sun-Young
    Park, Eun Su
    Kim, Jiyoung
    Kang, Jun
    Lee, Jae Jun
    Bae, Yoonjin
    Kim, Sang-Il
    Maeng, Lee-So
    PLOS ONE, 2015, 10 (10):
  • [10] Clinical significance of genotyping for human papillomavirus (HPV) 16 18/45 combined with cytology in cervical exfoliated cells in HPV oncogenic mRNA-positive women
    Wang, Jiajian
    Du, Ying
    Dong, Jie
    Zhou, Yuanping
    Wang, Pengfei
    Zhang, Xiaoxing
    Chen, Yingying
    He, Pingya
    GYNECOLOGIC ONCOLOGY, 2019, 153 (01) : 34 - 40
12345